Background: Autism spectrum disorder (ASD) is used to describe individuals with a specific combination of disorders in social communication and repetitive behaviors, highly restricted interests, and/or sensory behavior that begin early in life. The prevalence of ASD has been increasing rapidly in recent years. Pathophysiology of ASDs remains still unclear; however, genetic defects and multifactorial causes have been reported to play an important role in genetic disorders. The prevalence of inborn errors of metabolism (IEM) reported among patients with ASD is 2–5%. The clinical presentation of congenital disorders of glycosylation (CDG) may be in the form of psychiatric disorder only. Case Study: Case 1: a 5-year-old female patient was admitted for investigation of ASD. She had a dysmorphic facial appearance, inverted nipples, abnormal fat distribution, ataxic gait, and autistic features. Her transferrin isoelectric focusing test was compatible with a type 1 CDG pattern. A homozygous variant in ALG8 gene revealed the diagnosis of ALG8-CDG (CDG Type 1H). Case 2: a 2-year-old male patient was admitted with complaints of ASD for investigation of an underlying IEM due to speech delay. Physical examination revealed hypertelorism, small hands, and autistic behavior. Transferrin isoelectric focusing test was also found normal. As a result of the WES, a homozygous variant was detected in ALG11 confirming the diagnosis of CDG type 1p. Conclusion: CDG should also be considered in the differential diagnosis of autistic patients with dysmorphic findings. The aim of our study was to emphasize that autism should be listed among the neurological findings of CDG.

1.
Albokhari
D
,
Ng
BG
,
Guberinic
A
,
Daniel
EJP
,
Engelhardt
NM
,
Barone
R
et al
.
ALG8-CDG: molecular and phenotypic expansion suggests clinical management guidelines
.
J Inherit Metab Dis
.
2022
;
45
(
5
):
969
80
.
2.
Chantret
I
,
Dancourt
J
,
Dupre
T
,
Delenda
C
,
Bucher
S
,
Vuillaumier-Barrot
S
et al
.
A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation
.
J Biol Chem
.
2003
;
278
(
11
):
9962
71
.
3.
Cylwik
B
,
Naklicki
M
,
Chrostek
L
,
Gruszewska
E
.
Congenital disorders of glycosylation. Part I. Defects of protein N-glycosylation
.
Acta Biochim Pol
.
2013
;
60
(
2
):
151
61
.
4.
Centers for Disease Control and Prevention
.
Autism spectrum disorder homepage
2022
. Available from: https://www.cdc.gov/ncbddd/autism/screening.html.
5.
Haanpää
MK
,
Ng
BG
,
Gallant
NM
,
Singh
KE
,
Brown
C
,
Kimonis
V
et al
.
ALG11-CDG syndrome: expanding the phenotype
.
Am J Med Genet A
.
2019
;
179
(
3
):
498
502
.
6.
Helander
A
,
Stödberg
T
,
Jaeken
J
,
Matthijs
G
,
Eriksson
M
,
Eggertsen
G
.
Dolichol Kinase deficiency (DOLK-CDG) with a purely neurological presentation caused by a novel mutation
.
Mol Genet Metab
.
2013
;
110
(
3
):
342
4
.
7.
Höck
M
,
Wegleiter
K
,
Ralser
E
,
Kiechl-Kohlendorfer
U
,
Scholl-Bürgi
S
,
Fauth
C
et al
.
ALG8-CDG: novel patients and review of the literature
.
Orphanet J Rare Dis
.
2015
;
10
:
73
.
8.
Jaeken
J
,
Pe’anne
R
.
What is new in CDG
.
J Inherit Metab Dis
.
2017
;
40
(
4
):
569
86
.
9.
Kiykim
E
,
Zeybek
CA
,
Zubarioglu
T
,
Cansever
S
,
Yalcinkaya
C
,
Soyucen
E
et al
.
Inherited metabolic disorders in Turkish patients with autism spectrum disorders
.
Autism Res
.
2016
;
9
(
2
):
217
23
.
10.
Lord
C
,
Brugha
TS
,
Charman
T
,
Cusack
J
,
Dumas
G
,
Frazier
T
et al
.
Autism spectrum disorder
.
Nat Rev Dis Primers
.
2020
;
6
(
1
):
5
.
11.
Maenner
MJ
,
Shaw
KA
,
Bakian
AV
.
Prevalence and characteristics of autism spectrum disorder among children aged 8 years
.
Commonity Report Autism (Internet)
.
2021
. Available from: https://www.cdc.gov/ncbddd/autism/addm-community-report/documents/ADDM-Community-Autism-Report-12-2-021_Final-H.pdf.
12.
Marquardt
T
,
Denecke
J
.
Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies
.
Eur J Pediatr
.
2003
;
162
(
6
):
359
79
.
13.
Morava
E
,
Tiemes
V
,
Thiel
C
,
Seta
N
,
De Lonlay
P
,
De Klerk
H
et al
.
ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies
.
J Inherit Metab Dis
.
2016
;
39
(
5
):
713
23
.
14.
Rind
N
,
Schmeiser
V
,
Thiel
C
,
Absmanner
B
,
Lubbehusen
J
,
Hocks
J
et al
.
A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip
.
Hum Mol Genet
.
2010
;
19
(
8
):
1413
24
.
15.
Silver
G
,
Bahl
S
,
Cordeiro
D
,
Thakral
A
,
Athey
T
,
Mercimek-Andrews
S
.
Prevalence of congenital disorders of glycosylation in childhood epilepsy and effects of anti-epileptic drugs on the transferrin isoelectric focusing test
.
Genes
.
2021
;
12
(
8
):
1227
.
16.
Thiel
C
,
Rind
N
,
Popovici
D
,
Hoffmann
GF
,
Hanson
K
,
Conway
RL
et al
.
Improved diagnostics lead to identification of three new patients with congenital disorder of glycosylation-Ip
.
Hum Mutat
.
2012
;
33
(
3
):
485
7
.
17.
van Karnebeek
CD
,
Stockler-Ipsiroglu
S
.
Early identification of treatable inborn errors of metabolism in children with intellectual disability: the Treatable Intellectual Disability Endeavor protocol in British Columbia
.
Paediatr Child Health
.
2014
;
19
(
9
):
469
71
.
18.
Žigman
T
,
Petković Ramadža
D
,
Šimić
G
,
Barić
I
.
Inborn errors of metabolism associated with autism spectrum disorders: approaches to intervention
.
Front Neurosci
.
2021
;
15
:
673600
.
19.
Zilmer
M
,
Edmondson
AC
,
Khetarpal
SA
,
Alesi
V
,
Zaki
MS
,
Rostasy
K
et al
.
Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function
.
Brain
.
2020
;
143
(
4
):
1114
26
.
You do not currently have access to this content.